Ken Griffin Edwards Lifesciences Corp Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 4,234,570 shares of EW stock, worth $365 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,234,570
Previous 12,731,291
66.74%
Holding current value
$365 Million
Previous $996 Million
66.93%
% of portfolio
0.05%
Previous 0.18%
Shares
32 transactions
Others Institutions Holding EW
# of Institutions
1,457Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...